Use of abatacept in steroid refractory, immune checkpoint-induced myocarditis
Intern Med J
.
2021 Nov;51(11):1971-1972.
doi: 10.1111/imj.15566.
Authors
Vinod Kalapurackal Mathai
1
,
Allison Black
1
,
Sam Lovibond
2
,
Simon Binny
2
,
Jonathan Lipton
2
,
Cristina Moldovan
1
Affiliations
1
Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
2
Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
PMID:
34796633
DOI:
10.1111/imj.15566
No abstract available
Publication types
Letter
MeSH terms
Abatacept
Humans
Myocarditis* / chemically induced
Myocarditis* / drug therapy
Nivolumab
Steroids
Substances
Steroids
Nivolumab
Abatacept